oMeds
All comparisons
Comparison · sexual wellness

Daily Tadalafil vs On-Demand

Daily low-dose tadalafil maintains a steady plasma level so timing is no longer a variable. On-demand higher-dose tadalafil is used episodically and timed to activity. Both are provider-reviewed against cardiovascular history, current medications, lifestyle, and continuity preference. The choice is a lifestyle and pharmacokinetic match — not a potency comparison.

Reviewed by Dr. Laura PurdyMay 29, 2026
Attribute
Daily low-dose tadalafil
On-demand tadalafil
Dosing pattern
Daily, low dose
Same molecule, different cadence.
Episodic, higher dose
Timing dependency
None — always on board
Timed to activity
Plasma profile
Steady-state
Peak-and-decay
Lifestyle fit
Continuity-oriented
Episodic-oriented
Side-effect profile
Generally mild at low dose
Both share the PDE5-class profile.
Dose-dependent
Interaction with TRT or PDE5 needs
Continuous baseline
Layered episodically
Choose Daily low-dose tadalafil

Choose daily low-dose when continuity and removing timing as a variable matter, when frequency of activity is high or unpredictable, and when the low-dose tolerance profile fits.

Explore pathway
Choose On-demand tadalafil

Choose on-demand when activity is infrequent or planned, when a higher episodic dose is the right pharmacokinetic match, or when daily dosing is not appropriate for the patient's context.

Explore pathway

Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.

Frequently asked

Can the cadence be switched?

Yes — cadence is provider-reviewed against response, tolerance, and lifestyle. Switching is not a self-directed change.

Is sildenafil an alternative?

Yes. Sildenafil is a faster-onset, shorter-window PDE5 inhibitor. See the Tadalafil vs Sildenafil comparison for the molecule-level match.

Next step

Take the optimization assessment.

The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.

Begin assessment